Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease

Department of Department of Nephrology, Rigshospitalet, Copenhagen, Copenhagen

Department of Internal Medicine IV (Nephrology and Hypertension), Innsbruck

Department of Nephrology and Organ Transplant, CHU Rangueil, Toulouse

Centre Hospitalier Régional Universitaire de Lille, Nephrology Service, Lille

Nephrology Service CHU Bichat, Paris

PH USI UNTR, service du Pr Rondeau, Hôpital Tenon, Paris

Department of Nephrology, Uppsala University Hospital, Uppsala

Department of Department of nephrology, First Faculty of Medicine and General Teaching Hospital and Charles University in Prague, Czech Republic,, Prague

Department of Nephrology, Hemodialysis, Apheresis, and Transplantation, CHUGA (centre hospitalier universitaire Grenoble-Alpes), Grenoble

Karolinska University Hospital Huddinge, Stockholm